Skip to search formSkip to main contentSkip to account menu

epelsiban

Known as: (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-((1R)-1-(2,6-dimethylpyridin-3-yl)-2-(morpholin- 4-yl)-2-oxoethyl)-6-((1S)-1-methylpropyl)piperazine-2,5-dione, (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2,6- dimethylpyridin-3-yl)-2-(morpholin- 4-yl)-2-oxoethyl)-6- ((1S)-1-methylpropyl)piperazine-2,5-dione, 2,5-piperazinedione, 3-(2,3-dihydro-1h-inden-2-yl)-1-((1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl)-6-((1S)-1-methylpropyl)-, (3R,6R)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

DiketopiperazinesMorpholines
Epelsiban Besylate

Narrower (1)

GSK557296

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A single‐ and multiple‐dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers
An open‐label single‐ and repeat‐dose study was conducted to investigate the pharmacokinetics, safety, and tolerability of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)